Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells Journal Article
| Authors: | Wen, J.; Zhang, Y.; Chen, X.; Shen, L.; Li, G. C.; Xu, M. |
| Article Title: | Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells |
| Abstract: | We examined the effects of diallyl disulfide (DADS), an oil-soluble organosulfur compound found in garlic, on human HepG2 hepatoma cells to better understand its effect on apoptosis and apoptosis-related genes. Our study has demonstrated that DADS affects cell proliferation activity and viability and elicits typical apoptotic morphologic changes (chromatic condensation and nuclear fragmentation) in human HepG2 hepatoma cells. Also, treatment with DADS induces a temporary increase in phosphorylated p38 MAPK (phospho-p38) and phosphorylated p42/44 MAPK (phospho-p42/p44) in a time- and concentration- dependent manner. Inhibition of activated/phosphorylated mitogen-activated protein kinase (MAPK) with phospho-p38 or phospho-p42/44 specific inhibitors, SB203580 or U0126, induces apoptosis without DADS treatment, indicating that at least the endogenous activated forms of p38 MAPK and p42/p44 MAPK markedly exert cytoprotective roles from cell apoptosis in the HepG2 hepatoma cells. Combined treatment with these inhibitors followed by DADS further enhances the DADS-induced apoptosis. Taken together, these results show that both DADS and the specific inhibitors of MAPKs could induce apoptosis in HepG2 hepatoma cells and that the MAPKs inhibitors further enhance the apoptotic effect in DADS-treated HepG2 hepatoma cells. © 2004 Elsevier Inc. All rights reserved. |
| Keywords: | protein phosphorylation; human cell; liver cell carcinoma; carcinoma, hepatocellular; cell proliferation; cell viability; apoptosis; mitogen activated protein kinase inhibitor; enzyme activation; tumor cells, cultured; phosphorylation; drug synergism; enzyme inhibitors; mitogen-activated protein kinases; cell protection; cell activity; mapk; fragmentation reaction; diallyl disulfide; allyl compounds; disulfides; protein inhibitor; mitogen-activated protein kinase; synaptophysin; solubility; 1,4 diamino 1,4 bis(2 aminophenylthio) 2,3 dicyanobutadiene; garlic; mtt; 4 (4 fluorophenyl) 2 (4 methylsulfinylphenyl) 5 (4 pyridyl)imidazole; hepatoma cell; chromosome condensation; protein p42; humans; human; priority journal; article; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; dads; dmem; dulbecco's modified eagle medium; phospho-p38; phospho-p42/p44; phosphorylated p38 mapk; phosphorylated p42/44 mapk; organosulfur derivative; protein p44 |
| Journal Title: | Biochemical Pharmacology |
| Volume: | 68 |
| Issue: | 2 |
| ISSN: | 0006-2952 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2004-07-15 |
| Start Page: | 323 |
| End Page: | 331 |
| Language: | English |
| DOI: | 10.1016/j.bcp.2004.03.027 |
| PROVIDER: | scopus |
| PUBMED: | 15194004 |
| DOI/URL: | |
| Notes: | Biochem. Pharmacol. -- Cited By (since 1996):43 -- Export Date: 16 June 2014 -- CODEN: BCPCA -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work